AU2530700A - Serum albumin-based parenteral formulations of polyene macrolides - Google Patents

Serum albumin-based parenteral formulations of polyene macrolides

Info

Publication number
AU2530700A
AU2530700A AU25307/00A AU2530700A AU2530700A AU 2530700 A AU2530700 A AU 2530700A AU 25307/00 A AU25307/00 A AU 25307/00A AU 2530700 A AU2530700 A AU 2530700A AU 2530700 A AU2530700 A AU 2530700A
Authority
AU
Australia
Prior art keywords
serum albumin
parenteral formulations
polyene macrolides
based parenteral
macrolides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25307/00A
Inventor
Glen S. Kwon
Bong K. Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kinetana Inc
Original Assignee
Kinetana Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinetana Inc filed Critical Kinetana Inc
Publication of AU2530700A publication Critical patent/AU2530700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
AU25307/00A 1999-02-11 2000-02-10 Serum albumin-based parenteral formulations of polyene macrolides Abandoned AU2530700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24825499A 1999-02-11 1999-02-11
US09248254 1999-02-11
PCT/CA2000/000146 WO2000047187A1 (en) 1999-02-11 2000-02-10 Serum albumin-based parenteral formulations of polyene macrolides

Publications (1)

Publication Number Publication Date
AU2530700A true AU2530700A (en) 2000-08-29

Family

ID=22938320

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25307/00A Abandoned AU2530700A (en) 1999-02-11 2000-02-10 Serum albumin-based parenteral formulations of polyene macrolides

Country Status (2)

Country Link
AU (1) AU2530700A (en)
WO (1) WO2000047187A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413537B1 (en) 2000-03-10 2002-07-02 Wisconsin Alumni Research Foundation Nystatin formulation having reduced toxicity
KR20020062494A (en) * 2001-01-22 2002-07-26 유봉규 The composition of solid dispersion of polyethylene oxide containing monomeric polyenemacrolide antibiotics
AU2003234452A1 (en) * 2002-05-06 2003-11-11 Elan Pharma International Ltd. Nanoparticulate nystatin formulations
ES2212904B2 (en) * 2003-01-15 2006-02-16 Universidad Complutense De Madrid ANPHOTERICINE MICROSPHERES B.
WO2019074886A1 (en) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
CA3224729A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58216126A (en) * 1982-06-11 1983-12-15 Ono Pharmaceut Co Ltd Auxiliary for dissolution
DE3702105A1 (en) * 1987-01-24 1988-08-04 Bayer Ag PARENTERAL SOLUTION
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
FR2651680B1 (en) * 1989-09-14 1991-12-27 Medgenix Group Sa NOVEL PROCESS FOR THE PREPARATION OF LIPID MICROPARTICLES.
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins

Also Published As

Publication number Publication date
WO2000047187A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
AU2754700A (en) Busy-wait-free synchronization
AU9277698A (en) 9-amino-3-keto erythromycin derivatives
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU2861800A (en) Array centrifuge
AU4397700A (en) Combined preparations comprising anthracycline derivatives
AU2001278694A1 (en) Avermectin derivatives
AU4788200A (en) Pure delay estimation
AU7952800A (en) 2-alkoxybenzene derivatives
AU2530700A (en) Serum albumin-based parenteral formulations of polyene macrolides
AU2692200A (en) Enteral sorbefacients
AU4549999A (en) Novel polyene macrolide compounds and uses
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU8925398A (en) 3-descladinose 6-o-substituded erythromycin derivatives
AU4188500A (en) Protein c derivatives
AU6932098A (en) Erythromycin derivatives
AU1751801A (en) Protein c derivatives
HK1045698A1 (en) Avermectin derivatives
AU1688099A (en) Pharmaceutical preparation
AU2002346600A1 (en) 11-o-substituted macrolides and their descladinose derivatives
AU1504899A (en) Erythromycin derivatives
AU8869098A (en) Preparation of pyridine derivatives
AU6169400A (en) Flavonoid biosynthesis
AU1974900A (en) Macrolide intermediates in the preparation of clarithromycin
AU6911300A (en) Isomerase proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase